Postoperative dynamic survival of gastric cancer patients: A multi-institutional, international analysis of 22 265 patients.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 24 04 2019
accepted: 24 06 2019
pubmed: 19 7 2019
medline: 7 9 2019
entrez: 19 7 2019
Statut: ppublish

Résumé

How to best evaluate the disease-specific survival (DSS) of gastric cancer (GC) survivors over time is unclear. Clinicopathological data from 22 265 patients who underwent curative intend resection for GC were retrospectively analyzed. Changes in the patients' 3-year conditional disease-specific survival (CS3) were analyzed. We used time-dependent Cox regression to analyze which variables had long-term effects on DSS and devised a dynamic predictive model based on the length of survival. Based on 1-, 3-, and 5-year survivorships, the CS3 of the population increased gradually from 62% to 68.1%, 83.7%, and 90.6%, respectively. Subgroup analysis showed that the CS3 of patients who had poor prognostic factors initially demonstrated the greatest increase in postoperative survival time (eg, N3b: 26.6%-84.1%, Δ57.5% vs N0: 84.1%-93.3%, Δ9.2%). Time-dependent Cox regression analysis showed the following predictor variables constantly affecting DSS: age, the number of examined lymph nodes (LNs), T stage, N stage, and site (P < .05). These variables served as the basis for a dynamic prediction model. The influence of prognostic factors on DSS and CS3 changed dramatically over time. We developed an effective model for predicting the DSS of patients with GC based on the length of survival time.

Sections du résumé

BACKGROUND BACKGROUND
How to best evaluate the disease-specific survival (DSS) of gastric cancer (GC) survivors over time is unclear.
METHODS METHODS
Clinicopathological data from 22 265 patients who underwent curative intend resection for GC were retrospectively analyzed. Changes in the patients' 3-year conditional disease-specific survival (CS3) were analyzed. We used time-dependent Cox regression to analyze which variables had long-term effects on DSS and devised a dynamic predictive model based on the length of survival.
RESULTS RESULTS
Based on 1-, 3-, and 5-year survivorships, the CS3 of the population increased gradually from 62% to 68.1%, 83.7%, and 90.6%, respectively. Subgroup analysis showed that the CS3 of patients who had poor prognostic factors initially demonstrated the greatest increase in postoperative survival time (eg, N3b: 26.6%-84.1%, Δ57.5% vs N0: 84.1%-93.3%, Δ9.2%). Time-dependent Cox regression analysis showed the following predictor variables constantly affecting DSS: age, the number of examined lymph nodes (LNs), T stage, N stage, and site (P < .05). These variables served as the basis for a dynamic prediction model.
CONCLUSIONS CONCLUSIONS
The influence of prognostic factors on DSS and CS3 changed dramatically over time. We developed an effective model for predicting the DSS of patients with GC based on the length of survival time.

Identifiants

pubmed: 31317558
doi: 10.1002/jso.25637
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

685-697

Subventions

Organisme : 2017 Fujian Science and Technology Innovation Joint Fund Project
ID : 2017Y9004
Organisme : Construction Project of Fujian Province Minimally Invasive Medical Center
ID : [2017]171
Organisme : Scientific and Technological Innovation Joint Capital Projects of Fujian Province
ID : 2016Y9031
Organisme : The Second Batch of Special Support Funds for Fujian Province Innovation and Entrepreneurship Talents
ID : 2016B013
Organisme : CARIT Foundation (Fondazione Cassa di Risparmio di Terni e Nami)
ID : 0024137
Organisme : Youth Project of Fujian Provincial Health and Family Planning Commission
ID : 2016-1 to 41

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Jia-Bin Wang (JB)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Qing Zhong (Q)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Wei Wang (W)

Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangdong, China.

Jacopo Desiderio (J)

Department of Digestive Surgery, St. Mary's Hospital, University of Perugia, Terni, Italy.

Shi Chen (S)

Department of Esophageal and Gastrointestinal Surgery, The Sixth Hospital Affiliated to Sun Yat-sen University, Sun Yat-sen University Research Center of Diagnosis and Treatment of Gastric Cancer, Guangzhou, China.

Zhi-Yu Liu (ZY)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Qi-Yue Chen (QY)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Ping Li (P)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Jian-Wei Xie (JW)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Feng-Qiong Liu (FQ)

Department of Epidemiology and Health Statistic, School of Public Health, Fujian Medical University, Fuzhou, China.

Chao-Hui Zheng (CH)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Jun-Sheng Peng (JS)

Department of Esophageal and Gastrointestinal Surgery, The Sixth Hospital Affiliated to Sun Yat-sen University, Sun Yat-sen University Research Center of Diagnosis and Treatment of Gastric Cancer, Guangzhou, China.

Zhi-Wei Zhou (ZW)

Department of Gastric Surgery, Sun Yat-sen University Cancer Center, Guangdong, China.

Amilcare Parisi (A)

Department of Digestive Surgery, St. Mary's Hospital, University of Perugia, Terni, Italy.

Chang-Ming Huang (CM)

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Division of Gastric Cancer, Key Laboratory of Ministry of Education of Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH